Nalaganje...
KRAS: The Critical Driver and Therapeutic Target for Pancreatic Cancer
RAS genes (HRAS, KRAS, and NRAS) comprise the most frequently mutated oncogene family in human cancer. With the highest RAS mutation frequencies seen with the top three causes of cancer deaths in the United States (lung, colorectal, and pancreatic cancer), the development of anti-RAS therapies is a...
Shranjeno v:
| izdano v: | Cold Spring Harb Perspect Med |
|---|---|
| Main Authors: | , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Cold Spring Harbor Laboratory Press
2018
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5995645/ https://ncbi.nlm.nih.gov/pubmed/29229669 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1101/cshperspect.a031435 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|